Insider Transactions in Q2 2023 at Vanda Pharmaceuticals Inc. (VNDA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
16,000
-11.52%
|
$96,000
$6.29 P/Share
|
|
Jun 13
2023
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
14,600
-14.1%
|
$87,600
$6.56 P/Share
|
|
Jun 08
2023
|
Stephen Ray Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+32.57%
|
-
|
|
Jun 08
2023
|
Anne Sempowski Ward |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+30.57%
|
-
|
|
Jun 08
2023
|
Phaedra Chrousos |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+29.07%
|
-
|
|
Jun 08
2023
|
Richard W Dugan |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+15.05%
|
-
|
|
Jun 08
2023
|
Tage Honore |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+28.36%
|
-
|